Statistics
Publications
3
Citations
47
H-Index
3
Active since
2016
Affiliations
Lifang Jing is an author at Tianjin University of Science and Technology specializing in medicine, pharmacology, and steroid hormone signaling.
Publications per year
2016–2023
3
3
Lysosome Inhibitors Enhance the Chemotherapeutic Activity of Doxorubicin in HepG2 Cells
Yuyin Li, Yuejun Sun, Lifang Jing et al. · Chemotherapy · 2016 · 17 citations
Medicine, Oncology, Pharmacology +16
1–3 of 3